ω-Transaminase-Mediated Asymmetric Synthesis of (<i>S</i>)-1-(4-Trifluoromethylphenyl)Ethylamine

The pivotal role played by ω-transaminases (ω-TAs) in the synthesis of chiral amines used as building blocks for drugs and pharmaceuticals is widely recognized. However, chiral bulky amines are challenging to produce. Herein, a ω-TA (TR<sub>8</sub>) from a marine bacterium was used to sy...

Full description

Bibliographic Details
Main Authors: Carlos J. C. Rodrigues, Manuel Ferrer, Carla C. C. R. de Carvalho
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Catalysts
Subjects:
Online Access:https://www.mdpi.com/2073-4344/11/3/307
_version_ 1797395181071237120
author Carlos J. C. Rodrigues
Manuel Ferrer
Carla C. C. R. de Carvalho
author_facet Carlos J. C. Rodrigues
Manuel Ferrer
Carla C. C. R. de Carvalho
author_sort Carlos J. C. Rodrigues
collection DOAJ
description The pivotal role played by ω-transaminases (ω-TAs) in the synthesis of chiral amines used as building blocks for drugs and pharmaceuticals is widely recognized. However, chiral bulky amines are challenging to produce. Herein, a ω-TA (TR<sub>8</sub>) from a marine bacterium was used to synthesize a fluorine chiral amine from a bulky ketone. An analysis of the reaction conditions for process development showed that isopropylamine concentrations above 75 mM had an inhibitory effect on the enzyme. Five different organic solvents were investigated as co-solvents for the ketone (the amine acceptor), among which 25–30% (<i>v</i>/<i>v</i>) dimethyl sulfoxide (DMSO) produced the highest enzyme activity. The reaction reached equilibrium after 18 h at 30% of conversion. An in situ product removal (ISPR) approach using an aqueous organic two-phase system was tested to mitigate product inhibition. However, the enzyme activity initially decreased because the ketone substrate preferentially partitioned into the organic phase, <i>n</i>-hexadecane. Consequently, DMSO was added to the system to increase substrate mass transfer without affecting the ability of the organic phase to prevent inhibition of the enzyme activity by the product. Thus, the enzyme reaction was maintained, and the product amount was increased for a 62 h reaction time. The investigated ω-TA can be used in the bioconversion of bulky ketones to chiral amines for future bioprocess applications.
first_indexed 2024-03-09T00:30:46Z
format Article
id doaj.art-add0dd79bf3b426aa0ccf0d085866939
institution Directory Open Access Journal
issn 2073-4344
language English
last_indexed 2024-03-09T00:30:46Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Catalysts
spelling doaj.art-add0dd79bf3b426aa0ccf0d0858669392023-12-11T18:31:46ZengMDPI AGCatalysts2073-43442021-02-0111330710.3390/catal11030307ω-Transaminase-Mediated Asymmetric Synthesis of (<i>S</i>)-1-(4-Trifluoromethylphenyl)EthylamineCarlos J. C. Rodrigues0Manuel Ferrer1Carla C. C. R. de Carvalho2iBB-Institute for Bioengineering and Biosciences, Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisbon, PortugalInstitute of Catalysis, Consejo Superior de Investigaciones Científicas, 28049 Madrid, SpainiBB-Institute for Bioengineering and Biosciences, Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisbon, PortugalThe pivotal role played by ω-transaminases (ω-TAs) in the synthesis of chiral amines used as building blocks for drugs and pharmaceuticals is widely recognized. However, chiral bulky amines are challenging to produce. Herein, a ω-TA (TR<sub>8</sub>) from a marine bacterium was used to synthesize a fluorine chiral amine from a bulky ketone. An analysis of the reaction conditions for process development showed that isopropylamine concentrations above 75 mM had an inhibitory effect on the enzyme. Five different organic solvents were investigated as co-solvents for the ketone (the amine acceptor), among which 25–30% (<i>v</i>/<i>v</i>) dimethyl sulfoxide (DMSO) produced the highest enzyme activity. The reaction reached equilibrium after 18 h at 30% of conversion. An in situ product removal (ISPR) approach using an aqueous organic two-phase system was tested to mitigate product inhibition. However, the enzyme activity initially decreased because the ketone substrate preferentially partitioned into the organic phase, <i>n</i>-hexadecane. Consequently, DMSO was added to the system to increase substrate mass transfer without affecting the ability of the organic phase to prevent inhibition of the enzyme activity by the product. Thus, the enzyme reaction was maintained, and the product amount was increased for a 62 h reaction time. The investigated ω-TA can be used in the bioconversion of bulky ketones to chiral amines for future bioprocess applications.https://www.mdpi.com/2073-4344/11/3/307omega-transaminasebioconversionbulky ketonefluorine aminechiral aminemarine biocatalyst
spellingShingle Carlos J. C. Rodrigues
Manuel Ferrer
Carla C. C. R. de Carvalho
ω-Transaminase-Mediated Asymmetric Synthesis of (<i>S</i>)-1-(4-Trifluoromethylphenyl)Ethylamine
Catalysts
omega-transaminase
bioconversion
bulky ketone
fluorine amine
chiral amine
marine biocatalyst
title ω-Transaminase-Mediated Asymmetric Synthesis of (<i>S</i>)-1-(4-Trifluoromethylphenyl)Ethylamine
title_full ω-Transaminase-Mediated Asymmetric Synthesis of (<i>S</i>)-1-(4-Trifluoromethylphenyl)Ethylamine
title_fullStr ω-Transaminase-Mediated Asymmetric Synthesis of (<i>S</i>)-1-(4-Trifluoromethylphenyl)Ethylamine
title_full_unstemmed ω-Transaminase-Mediated Asymmetric Synthesis of (<i>S</i>)-1-(4-Trifluoromethylphenyl)Ethylamine
title_short ω-Transaminase-Mediated Asymmetric Synthesis of (<i>S</i>)-1-(4-Trifluoromethylphenyl)Ethylamine
title_sort ω transaminase mediated asymmetric synthesis of i s i 1 4 trifluoromethylphenyl ethylamine
topic omega-transaminase
bioconversion
bulky ketone
fluorine amine
chiral amine
marine biocatalyst
url https://www.mdpi.com/2073-4344/11/3/307
work_keys_str_mv AT carlosjcrodrigues ōtransaminasemediatedasymmetricsynthesisofisi14trifluoromethylphenylethylamine
AT manuelferrer ōtransaminasemediatedasymmetricsynthesisofisi14trifluoromethylphenylethylamine
AT carlaccrdecarvalho ōtransaminasemediatedasymmetricsynthesisofisi14trifluoromethylphenylethylamine